70 related articles for article (PubMed ID: 33232882)
1. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells.
Singh B; Patwardhan RS; Jayakumar S; Sharma D; Sandur SK
J Photochem Photobiol B; 2020 Dec; 213():112080. PubMed ID: 33232882
[TBL] [Abstract][Full Text] [Related]
2. Targeting NRF2, Regulator of Antioxidant System, to Sensitize Glioblastoma Neurosphere Cells to Radiation-Induced Oxidative Stress.
Godoy PRDV; Pour Khavari A; Rizzo M; Sakamoto-Hojo ET; Haghdoost S
Oxid Med Cell Longev; 2020; 2020():2534643. PubMed ID: 32617133
[TBL] [Abstract][Full Text] [Related]
3. Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis.
Rai A; Patwardhan RS; Jayakumar S; Pachpatil P; Das D; Panigrahi GC; Gota V; Patwardhan S; Sandur SK
Acta Pharmacol Sin; 2024 Jul; 45(7):1506-1519. PubMed ID: 38480835
[TBL] [Abstract][Full Text] [Related]
4. Acquired radioresistance in EMT6 mouse mammary carcinoma cell line is mediated by CTLA-4 and PD-1 through JAK/STAT/PI3K pathway.
Sham NFR; Hasani NAH; Hasan N; Karim MKA; Fuad SBSA; Hasbullah HH; Ibahim MJ
Sci Rep; 2023 Feb; 13(1):3108. PubMed ID: 36813833
[TBL] [Abstract][Full Text] [Related]
5. Predominant factors influencing reactive oxygen species in cancer stem cells.
Soundararajan L; Warrier S; Dharmarajan A; Bhaskaran N
J Cell Biochem; 2024 Jan; 125(1):3-21. PubMed ID: 37997702
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models.
Qian S; Fang Y; Yao C; Wang Y; Zhang Z; Wang X; Gao J; Feng Y; Sun L; Zou R; Zhou G; Ye J; Xia R; Xia H
Oncol Res; 2022; 30(2):53-64. PubMed ID: 37305326
[TBL] [Abstract][Full Text] [Related]
7. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.
You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer.
Naumann FV; Sweep FCGJ; Adema GJ; Peeters WJM; Martens JWM; Bussink J; Span PN
Cancer Metab; 2023 Feb; 11(1):3. PubMed ID: 36755288
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism.
Wang S; Han J; Wang Z; Liu X; Wang C; Nisar MF; Pan L; Xu K
Curr Comput Aided Drug Des; 2024 May; ():. PubMed ID: 38818918
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis.
Tang H; Liu S; Yan X; Jin Y; He X; Huang H; Liu L; Hu W; Wu A
Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759607
[TBL] [Abstract][Full Text] [Related]
11. Radiation-resistant bacteria in desiccated soil and their potentiality in applied sciences.
Khan A; Liu G; Zhang G; Li X
Front Microbiol; 2024; 15():1348758. PubMed ID: 38894973
[TBL] [Abstract][Full Text] [Related]
12. Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy.
Wang S; Cao H; Zhao CC; Wang Q; Wang D; Liu J; Yang L; Liu J
Sci China Life Sci; 2024 Jul; 67(7):1398-1412. PubMed ID: 38602587
[TBL] [Abstract][Full Text] [Related]
13. The emergence of tumor-initiating cells in an advanced hypopharyngeal tumor model exhibits enhanced angiogenesis and nuclear factor erythroid 2-related factor 2 associated antioxidant effects.
Lin MY; Wang CY; Chan YH; Su SP; Chiang HK; Yang MH; Lee YJ
Antioxid Redox Signal; 2024 Apr; ():. PubMed ID: 38661516
[TBL] [Abstract][Full Text] [Related]
14. Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma.
Clerici S; Boletta A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233657
[TBL] [Abstract][Full Text] [Related]
15. Sirtuins' control of autophagy and mitophagy in cancer.
Aventaggiato M; Vernucci E; Barreca F; Russo MA; Tafani M
Pharmacol Ther; 2021 May; 221():107748. PubMed ID: 33245993
[TBL] [Abstract][Full Text] [Related]
16. Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients.
Patwardhan RS; Rai A; Sharma D; Sandur SK; Patwardhan S
Heliyon; 2024 Mar; 10(6):e27011. PubMed ID: 38524569
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular subgroups and establishment of risk model based on the response to oxidative stress to predict overall survival of patients with lung adenocarcinoma.
Liu L; Hou Q; Chen B; Lai X; Wang H; Liu H; Wu L; Liu S; Luo K; Liu J
Eur J Med Res; 2023 Sep; 28(1):333. PubMed ID: 37689745
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide-based theranostics - a promising strategy for lung cancer.
Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181
[TBL] [Abstract][Full Text] [Related]
19. Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.
Zhou T; Zhang LY; He JZ; Miao ZM; Li YY; Zhang YM; Liu ZW; Zhang SZ; Chen Y; Zhou GC; Liu YQ
Front Immunol; 2023; 14():1133899. PubMed ID: 36865554
[TBL] [Abstract][Full Text] [Related]
20. Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism.
Bian C; Zheng Z; Su J; Wang H; Chang S; Xin Y; Jiang X
Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
